EPISODE · Oct 15, 2025 · 23 MIN
LifeVantage (LFVN): Activating the Next Phase of Growth Through Science and Synergy
from WTR Small-Cap Spotlight · host Water Tower Research
Send us Fan MailIn this episode of the WTR Small-Cap Spotlight podcast, Steve Fife, President & CEO, and Carl Aure, CFO of LifeVantage (NASDAQ: LFVN), join Tim Gerdeman and Doug Lane of Water Tower Research to discuss the company’s acquisition of LoveBiome, a fast-growing leader in gut health and direct sales.They explore how the deal strengthens LifeVantage’s foundation in nutrigenomics, expands its presence in the rapidly growing $14B gut health market, and creates synergies across product lines like P84 and MindBody. Fife and Aure also discuss the integration of consultant networks, expected financial impact, and how LifeVantage is positioning for long-term, science-driven growth.
What this episode covers
Send us Fan Mail In this episode of the WTR Small-Cap Spotlight podcast, Steve Fife, President & CEO, and Carl Aure, CFO of LifeVantage (NASDAQ: LFVN), join Tim Gerdeman and Doug Lane of Water Tower Research to discuss the company’s acquisition of LoveBiome, a fast-growing leader in gut health and direct sales. They explore how the deal strengthens LifeVantage’s foundation in nutrigenomics, expands its presence in the rapidly growing $14B gut health market, and creates synergies across pr...
NOW PLAYING
LifeVantage (LFVN): Activating the Next Phase of Growth Through Science and Synergy
No transcript for this episode yet
Similar Episodes
Jun 12, 2025 ·30m
Apr 22, 2025 ·32m
Apr 17, 2025 ·16m
Feb 27, 2025 ·0m
Dec 16, 2024 ·39m